Hepatitis C virus epidemiology in Djibouti, Somalia, Sudan, and Yemen: Systematic review and meta-analysis

PLoS ONE

Volumn 11, Issue 2, 2016, Pages

  Chaabna, Karima ^a,b   Kouyoumjian, Silva P ^a   Abu Raddad, Laith J ^a,b,c  

^a Qatar Foundation Education City ^*  (Qatar)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HAMAD BIN KHALIFA UNIVERSITY   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS ANTIBODY;

HEMODIALYSIS; HEMOPHILIA; HEPATITIS C; HIGH RISK POPULATION; HUMAN; INFECTION RATE; INFECTION RISK; MEN WHO HAVE SEX WITH MEN; PREVALENCE; REVIEW; SOMALIA; SUDAN; SYSTEMATIC REVIEW; YEMEN; DJIBOUTI; FEMALE; HEPACIVIRUS; MALE; META ANALYSIS; PATHOGENICITY;

DJIBOUTI; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; PREVALENCE; SOMALIA; SUDAN; YEMEN;

EID: 84960504338     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149966     Document Type: Review

References (131)

1. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, et al. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet (London, England). 2000; 355(9207):887-91. Epub 2001/02/07. PMID: 10752705.
2. Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology (Baltimore, Md). 2006; 43(5):915-22. Epub 2006/04/22. doi: 10.1002/hep.21173 PMID: 16628669.
3. Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver international: official journal of the International Association for the Study of the Liver. 2011; 31 Suppl 2:30-60. Epub 2011/06/18. doi: 10.1111/j.1478-3231.2011.02539.x PMID: 21651702.
4. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2011; 17 (2):107-15. Epub 2010/11/26. doi: 10.1111/j.1469-0691.2010.03432.x PMID: 21091831.
5. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology (Baltimore, Md). 2013; 57(4):1333-42. Epub 2012/11/23. 10.1002/hep.26141. PMID: 23172780.
6. El-Zanaty F, Way A. Egypt Demographic and Health Survey 2008. Cairo: Egyptian Ministry of Health, National Population Council, El-Zanaty and Associates, and ORC Macro; 2009. 431 p.
7. Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC infectious diseases. 2013; 13:288. doi: 10.1186/1471-2334-13-288 PMID: 23799878; PubMed Central PMCID: PMC3702438.
8. Chaabna K, Mohamoud YA, Chemaitelly H, Mumtaz GR, Abu-Raddad LJ. Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in the Horn of Africa sub-region of the Middle East and North Africa. Systematic reviews. 2014; 3:146. Epub 2014/12/18. doi: 10.1186/2046-4053-3-146 PMID: 25516265; PubMed Central PMCID: PMCPmc4274704.
9. Chaabna K, Mohamoud YA, Chemaitelly H, Mumtaz GR, Abu-Raddad LJ. Protocol for a systematic review and meta-analysis of hepatitis C virus (HCV) prevalence and incidence in The Horn of Africa sub-region of the Middle East and North Africa. 2014. Available at: http://www.crd.york.ac.uk/NIHR-PROSPERO/display-record.asp?ID=CRD42014010318#.VRpKHuEQuCd 2014.
10. Mohamoud YA, Riome S, Abu-Raddad LJ. The epidemiology of hepatitis C virus in the Arabian Gulf countries: Systematic review and meta-analyses (In press). 2015.
11. Mahmud S, Akbarzadeh V, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Iran: Systematic review and meta-analyses (In press). 2015.
12. Fadlalla FA, Mohamoud YA, Mumtaz GR, Abu-Raddad LJ. The epidemiology of hepatitis C virus in the maghreb region: systematic review and meta-analyses. PloS one. 2015; 10(3):e0121873. Epub 2015/03/25. doi: 10.1371/journal.pone.0121873 PMID: 25803848.
13. Chemaitelly H, Chaabna K, Abu-Raddad LJ. The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis. PloS one. 2015; 10(8):e0135281. Epub 2015/08/22. doi: 10.1371/journal.pone.0135281 PMID: 26296200.
14. Chemaitelly H, Mahmud S, Rahmani AM, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Afghanistan: Systematic review and meta-analysis. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2015. Epub 2015/09/30. doi: 10.1016/j.ijid.2015.09.011 PMID: 26417880.
15. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. Journal of clinical epidemiology. 2009; 62(10):1006-12. Epub 2009/07/28. doi: 10.1016/j.jclinepi.2009.06.005 PMID: 19631508.
16. WHO. World Health Organization African Index Medicus (AIM database) [cited 2014]. Available from: http://indexmedicus.afro.who.int/cgi-bin/wxis.exe/iah/?IsisScript=iah/iah.xis&lang=I&base=AIM.
17. WHO. World Health Organization Index Medicus for the Eastern Mediterranean Region (IMEMR). Available from: http://www.emro.who.int/information-resources/imemr/imemr.html.
18. Yemeni Journal of Medical Sciences. 2015. Available at: http://ust.edu/ojs/index.php?journal=yjmp 2015. Available from: http://ust.edu/ojs/index.php?journal=yjmp.
19. Sudan Journal of Medical Sciences. 2015. Available at: http://www.ajol.info/index.php/sjms/index. Available from: http://www.ajol.info/index.php/sjms/index.
20. Sudan Medical Journal. 2015. Available at: http://www.smj.eg.net/. Available from: http://www.smj.eg. net/.
21. Abu-Raddad L, Akala FA, Semini I, Riedner G, Wilson D, Tawil O. Characterizing the HIV/AIDS epidemic in the Middle East and North Africa: Time for Strategic Action. Middle East and North Africa HIV/AIDS Epidemiology Synthesis Project. World Bank/UNAIDS/WHO Publication. Washington DC: The World Bank Press. World Bank/UNAIDS/WHO Publication. Washington DC: The World Bank Press, 2010.
22. Abu-Raddad LJ, Hilmi N, Mumtaz G, Benkirane M, Akala FA, Riedner G, et al. Epidemiology of HIV infection in the Middle East and North Africa. AIDS (London, England). 2010; 24 Suppl 2:S5-23. Epub 2010/07/17. PMID: 20610949.
23. International AIDS Society conferences. 2015. Available at: https://www.iasociety.org/Default.aspx?pageId=3. Available from: https://www.iasociety.org/Default.aspx?pageId=3.
24. NIH. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA)-A Scientific Workshop to Promote Research Collaborations, Doha, Qatar. Available at: https://respond. niaid.nih.gov/conferences/qatarmenaworkshop/Pages/default.aspx 2014. Available from: https://respond.niaid.nih.gov/conferences/qatarmenaworkshop/Pages/default.aspx.
25. Shire AM, Sandhu DS, Kaiya JK, Oseini AM, Yang JD, Chaiteerakij R, et al. Viral hepatitis among Somali immigrants in Minnesota: association of hepatitis C with hepatocellular carcinoma. Mayo Clinic proceedings. 2012; 87(1):17-24. Epub 2012/01/04. doi: 10.1016/j.mayocp.2011.08.001 PMID: 22212964; PubMed Central PMCID: PMCPmc3337857.
26. Endnote X7. Thomson Reuters, San Francisco, CA. Available at: http://endnote.com/downloads.
27. R v.3.1.1. R Development Core Team, 2011. Available at: http://cran.r-project.org/bin/windows/base/.
28. Schwarzer G. General Package for Meta-Analysis. Version 4.1-0. Available at: http://cran.r-project.org/web/packages/meta/meta.pdf 2015. Available from: http://cran.r-project.org/web/packages/meta/meta.pdf.
29. Stata/se 13.1. StataCorp. Stata: Release 13. Statistical Software. College Station, TX: StataCorp LP. 2013.
30. Clopper CJ, P E.S. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometricka. 1934; 26:404-13.
31. Freeman M, Tukey J. Transformations related to the angular and the square root. The Annals of Mathematical Statistics. 1950; 21:607-11.
32. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials. 1986; 7(3):177-88. Epub 1986/09/01. PMID: 3802833.
33. Miller JJ. The inverse of the Freeman-Tuckey double arcine transformation. The American Statistician. 1978; 32(4):138.
34. Schwarzer G. Meta package. 2014.
35. Cochran W. The combination of estimates from different experiments. Biometrics. 1954; 10(1):101-29.
36. Higgins J, Thompson S, Deeks J, Altman D. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003; 327:557-60.
37. Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ (Clinical research ed). 2011; 342:d549. Epub 2011/02/12. doi: 10.1136/bmj.d549 PMID: 21310794.
38. Borenstein M. Introduction to meta-analysis. Chichester, U.K.: John Wiley & Sons; 2009. xxviii, 421 p. p.
39. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002; 21(11):1539-58. Epub 2002/07/12. doi: 10.1002/sim.1186 PMID: 12111919.
40. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Collaboration TC, editor2008.
41. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014; 61(1 Suppl):S45-57. doi: 10.1016/j.jhep.2014. 07.027 PMID: 25086286.
42. Galea S, Tracy M. Participation rates in epidemiologic studies. Annals of epidemiology. 2007; 17 (9):643-53. Epub 2007/06/08. doi: 10.1016/j.annepidem.2007.03.013 PMID: 17553702.
43. Dray X, Dray-Spira R, Bronstein JA, Mattera D. [Prevalences of HIV, hepatitis B and hepatitis C in blood donors in the Republic of Djibouti]. Med Trop (Mars). 2005; 65(1):39-42. Epub 2005/05/21. PMID: 15903075.
44. Aceti A, Taliani G, Bruni R, Sharif OS, Moallin KA, Celestino D, et al. Hepatitis C virus infection in chronic liver disease in Somalia. Am J Trop Med Hyg. 1993; 48(4):581-4. Epub 1993/04/01. PMID: 7683179.
45. Nur YA, Groen J, Elmi AM, Ott A, Osterhaus AD. Prevalence of serum antibodies against bloodborne and sexually transmitted agents in selected groups in Somalia. Epidemiology and infection. 2000; 124 (1):137-41. Epub 2000/03/18. PMID: 10722141; PubMed Central PMCID: PMCPmc2810894.
46. Watts DM, Corwin AL, Omar MA, Hyams KC. Low risk of sexual transmission of hepatitis C virus in Somalia. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1994; 88(1):55-6. Epub 1994/01/01. PMID: 8154002.
47. Bile K, Aden C, Norder H, Magnius L, Lindberg G, Nilsson L. Important role of hepatitis C virus infection as a cause of chronic liver disease in Somalia. Scand J Infect Dis. 1993; 25(5):559-64. Epub 1993/01/01. PMID: 7506842.
48. Bile K, Mohamud O, Aden C, Isse A, Norder H, Nilsson L, et al. The risk for hepatitis A, B, and C at two institutions for children in Somalia with different socioeconomic conditions. Am J Trop Med Hyg. 1992; 47(3):357-64. Epub 1992/09/01. PMID: 1524149.
49. WHO. EMRO Annual HIV STI reporting form SOMALIA 2011-Hepatitis C. 2011.
50. Mohamedani A. Prevalence of Hepatitis C Virus Antibodies in Patients with Schistosomiasis in Gezira State in Central Sudan. Endemic and Emerging Viral Diseases of Priority in the Middle East and North Africa (MENA)-A Scientific Workshop to Promote Research Collaboration; May 2014; Doha, Qatar2014. p. 86.
51. Mudawi HM, Smith HM, Fletcher IA, Fedail SS. Prevalence and common genotypes of HCV infection in Sudanese patients with hepatosplenic schistosomiasis. Journal of medical virology. 2007; 79 (9):1322-4. Epub 2007/07/04. doi: 10.1002/jmv.20865 PMID: 17607776.
52. Mudawi HM, Smith HM, Rahoud SA, Fletcher IA, Babikir AM, Saeed OK, et al. Epidemiology of HCV infection in Gezira state of central Sudan. Journal of medical virology. 2007; 79(4):383-5. Epub 2007/02/22. doi: 10.1002/jmv.20780 PMID: 17311341.
53. Gadour MOEH, Mohamed BT. HBV, HCV and HIV among patients with Hemophilia in Khartoum-Sudan. Sudan Journal of Medical Sciences. 2011; 6(4):233-7.
54. El-Amin HH, Osman EM, Mekki MO, Abdelraheem MB, Ismail MO, Yousif ME, et al. Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2007; 18(1):101-6. Epub 2007/01/24. PMID: 17237901.
55. Gasim GI, Hamdan HZ, Hamdan SZ, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections among hemodialysis patients in Khartoum, Sudan. Journal of medical virology. 2012; 84(1):52-5. Epub 2011/11/05. doi: 10.1002/jmv.22256 PMID: 22052648.
56. Suliman SM, Fessaha S, El Sadig M, El-Hadi MB, Lambert S, Fields H, et al. Prevalence of hepatitis C virus infection in hemodialysis patients in Sudan. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 1995; 6 (2):154-6. Epub 1995/04/01. PMID: 18583856.
57. IBBS National Team. Integrated bio-behavioral HIV surveillance (IBBS) among female sex workers and men who have sex with men in 15 states of Sudan, 2011-2012. 2013.
58. Nail A, Eltiganni S, Imam A. Seroprevalence of Hepatitis B and C among health care workers in Omdurman, Sudan. Sudan Journal of Medical Sciences. 2008; 3(3):201-5.
59. Mudawi H, Hussein W, Mukhtar M, Yousif M, Nemeri O, Glebe D, et al. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2014; 29:65-70. Epub 2014/12/03. doi: 10.1016/j.ijid.2014.07.004 PMID: 25449238.
60. McCarthy MC, el-Tigani A, Khalid IO, Hyams KC. Hepatitis B and C in Juba, southern Sudan: results of a serosurvey. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1994; 88 (5):534-6. Epub 1994/09/01. PMID: 7992329.
61. Omer RE, Van't Veer P, Kadaru AM, Kampman E, el Khidir IM, Fedail SS, et al. The role of hepatitis B and hepatitis C viral infections in the incidence of hepatocellular carcinoma in Sudan. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2001; 95(5):487-91. Epub 2001/11/15. PMID: 11706655.
62. Ahmed RE, Karsany MS, Adam I. Brief report: acute viral hepatitis and poor maternal and perinatal outcomes in pregnant Sudanese women. Journal of medical virology. 2008; 80(10):1747-8. Epub 2008/08/21. doi: 10.1002/jmv.21284 PMID: 18712815.
63. Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I. Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J. 2007; 4:104. Epub 2007/10/26. doi: 10.1186/1743-422x-4-104 PMID: 17958904; PubMed Central PMCID: PMCPmc2116999.
64. Abou MA, Eltahir YM. Seropositivity of hepatitis B virus and hepatitis C virus dual infection among blood donors in Nyala teaching hospital. Virol J. 2009; 6:227. Epub 2009/12/24. doi: 10.1186/1743-422x-6-227 PMID: 20028507; PubMed Central PMCID: PMCPmc2804613.
65. Nagi AM, Al Tayeb HA, Ahmed MA. Seroprevalence of hepatitis Band C viral infections among blood donors in Shendi, River Nile State, Sudan. Research Journal of Medicine and Medical Sciences. 2007; 2(2):122-6.
66. Elfaki AMH, Eldour AAA, Elsheikh NMH. Sero-prevalence of immunodeficiency virus, hepatitis B and C and syphilis among blood donors at ElObeid Teaching Hospital, West Sudan. Sudan Journal of Medical Sciences. 2008; 3(4):333-7.
67. Osman AMM, Minrghani OA, Gasim GI, Adam I. Hepatitis B Virus, Hepatitis C Virus and Human Immunodeficiency Virus Infection among Pregnant Women in Central Sudan. Sudanese Journal of Medical Sciences. 2014; 9(2):91-5.
68. Haidar NA. Prevalence of hepatitis B and hepatitis C in blood donors and high risk groups in Hajjah, Yemen Republic. Saudi Med J. 2002; 23(9):1090-4. Epub 2002/10/09. PMID: 12370719.
69. Aman K, Al-Dubai SA, Aman R, Hawash A, Alshagga M, Kassim S. Prevalence and associated factors of hepatitis C virus infection among renal disease patients on maintenance hemodialysis in three health centers in Aden, Yemen: a cross sectional study. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2015; 26(2):380-5. Epub 2015/03/12. PMID: 25758898.
70. Selm SB. Prevalence of hepatitis C virus infection among hemodialysis patients in a single center in Yemen. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia. 2010; 21(6):1165-8. Epub 2010/11/10. PMID: 21060200.
71. Al-Jarba AS, Al-Sayyari WM. Prevalence of hepatitis B virus and hepatitis C virus in health workers in 3 major hospitals in Aden, Republic of Yemen. Saudi Med J. 2003; 24(9):1031-2. Epub 2003/09/16. PMID: 12973499.
72. Shidrawi R, Ali Al-Huraibi M, Ahmad Al-Haimi M, Dayton R, Murray-Lyon IM. Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers. Journal of medical virology. 2004; 73(4):562-5. Epub 2004/06/29. doi: 10.1002/jmv.20126 PMID: 15221900.
73. Denis F, Aussel L, Ranger S, Martin P, Itoua-N'Gaporo A, Frommel D, et al. Prevalence of antibodies to hepatitis C virus among patients with leprosy in several African countries and the Yemen. Journal of medical virology. 1994; 43(1):1-4. Epub 1994/05/01. PMID: 7521898.
74. Gunaid AA, Nasher TM, el-Guneid AM, Hill M, Dayton R, Pal A, et al. Acute sporadic hepatitis in the Republic of Yemen. Journal of medical virology. 1997; 51(1):64-6. Epub 1997/01/01. PMID: 8986951.
75. Al-Mansoob AS, Salem AK, A-Selwi A.H.A., Assamawi A. Risk factors of hepatitis B and C viruses among patients admitted in surgical departments at Al-Thawra Hospital, Sana'a, Yemen. Sudan Medical Journal. 2013; 49(3):168-75. Epub December 2013.
76. Al-Moslih MI, Al-Huraibi MA. Prevalence of hepatitis C virus among patients with liver disease in the Republic of Yemen. East Mediterr Health J. 2001; 7(4-5):771-8. Epub 2004/08/31. PMID: 15332778.
77. Saeed NM, Bawazir AA, Al-Zuraiqi M, Al-Negri F, Yunus F. Why is hepatocellular carcinoma less attributable to viral hepatitis in Yemen? Asian Pacific journal of cancer prevention: APJCP. 2012; 13 (8):3663-7. Epub 2012/10/27. PMID: 23098451.
78. Salem AK. Prevalence of HCV among Yemeni patients with non-Hodgkin's lymphoma at AI-Thawra teaching hospital. Gulf J Oncolog. 2009;(5:):22-9. Epub 2010/01/21. PMID: 20084782.
79. Salem AK, Abdulrab A, Alfakeh Y, Aown A. Hepatocellular carcinoma in Yemeni patients: a single centre experience over an 8-year period. East Mediterr Health J. 2012; 18(7):693-9. Epub 2012/08/16. PMID: 22891515.
80. El Guneid AM, Gunaid AA, O'Neill AM, Zureikat NI, Coleman JC, Murray-Lyon IM. Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease. Journal of medical virology. 1993; 40(4):330-3. Epub 1993/08/01. PMID: 8228926.
81. Bakhubaira S. Hepatitis B, C and human immune deficiency virus among cancer patients attending the National Cancer of Public Health Laboratories-Aden. Abstracts of Researches. 2009; 13(2).
82. Al-Selwi AHA, Elezzy Y, Al Ghazali J, Hadi S. Association of hepatocellular carcinoma with hepatic viral markers B and C among Yemenis patients at Althawra Hospital Sana'a. Sudan Medical Journal. 2009; 4(3):237-42.
83. Al-Waleedi AA, Khader YS. Prevalence of hepatitis B and C infections and associated factors among blood donors in Aden City, Yemen. East Mediterr Health J. 2012; 18(6):624-9. Epub 2012/08/15. PMID: 22888620.
84. Sallam TA, Tong CY, Cuevas LE, Raja'a YA, Othman AM, Al-Kharsa KR. Prevalence of blood-borne viral hepatitis in different communities in Yemen. Epidemiology and infection. 2003; 131(1):771-5. Epub 2003/09/02. PMID: 12948378; PubMed Central PMCID: PMCPmc2870019.
85. Murad EA, Babiker SM, Gasim GI, Rayis DA, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Sana'a, Yemen. BMC Pregnancy Childbirth. 2013; 13:127. Epub 2013/06/14. doi: 10.1186/1471-2393-13-127 PMID: 23758990; PubMed Central PMCID: PMCPmc3684507.
86. Scott DA, Constantine NT, Callahan J, Burans JP, Olson JG, al-Fadeel M, et al. The epidemiology of hepatitis C virus antibody in Yemen. Am J Trop Med Hyg. 1992; 46(1):63-8. Epub 1992/01/01. PMID: 1311155.
87. Al-Shamiri AH, Al-Taj MA, Ahmed AS. Prevalence and co-infections of schistosomiasis/hepatitis B and C viruses among school children in an endemic areas in Taiz, Yemen. Asian Pac J Trop Med. 2011; 4(5):404-8. Epub 2011/07/21. doi: 10.1016/s1995-7645(11)60113-2 PMID: 21771686.
88. Omer HH. Distribution of Hepatitis B virus, and Hepatitis C virus among blood donors in Aden Blood Center. Abstracts of Researches. 2010; 14(1):7.
89. Gray GC, Kassira EN, Rodier GR, Myers MC, Calamaio CA, Gregory M, et al. Remote village survey for agents causing hepatosplenic disease in the Republic of Yemen. Tropical doctor. 1999; 29 (4):212-9. Epub 1999/12/01. PMID: 10578634.
90. Alodini A. Prevalence of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Infection among Blood Donors at Al-Thawra Hospital Sana'a City-Yemen. Yemeni Journal for Medical Sciences. 2012; 6:16-20.
91. Oshaish HA, El Shazly H, Elabsii AR. Prevalence of HBS Ag virus, anti-hepatitis C virus and anti-HIV among volunteer blood donor in Taiz private hospital, Yemen Republic. Assiut Medical Journal. 2008; 32(3):163-70.
92. Saghir SAM, Al-Hassan FM, Alsalahi OSA, Alhariry AEAA, Baqir HS. Frequencies of HBV, HCV, HIV, and syphilis markers among blood donors: A hospital-based study in Hodeidah, Yemen. Tropical Journal of Pharmaceutical Research. 2012; 11(1):132-6. http://dx.doi.org/10.4314/tjpr.v11i1.17.
93. Gacche RN, Al-Mohani SK. Seroprevalence and Risk Factors for Hepatitis C Virus Infection among General Population in Central Region of Yemen. Hepat Res Treat. 2012; 2012:689726. Epub 2013/01/16. doi: 10.1155/2012/689726 PMID: 23320156; PubMed Central PMCID: PMCPmc3536035.
94. Daw MA, Dau AA. Hepatitis C virus in Arab world: a state of concern. The Scientific World Journal. 2012; 2012:719494. Epub 2012/05/26. doi: 10.1100/2012/719494 PMID: 22629189; PubMed Central PMCID: PMCPmc3354686.
95. Mudawi HM. Epidemiology of viral hepatitis in Sudan. Clinical and experimental gastroenterology. 2008; 1:9-13. Epub 2008/01/01. PMID: 21677820; PubMed Central PMCID: PMCPmc3108625.
96. El-Zanaty F, Way A. Egypt Demographic and Health Survey 2008. Cairo, Egypt: Ministry of Health, El-Zanaty and Associates, and Macro International, 2009.
97. Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2009; 13(1):9-19. Epub 2008/10/07. doi: 10.1016/j.ijid.2008. 06.019 PMID: 18835208; PubMed Central PMCID: PMCPmc2651958.
98. Umar M, Bushra HT, Ahmad M, Data A, Ahmad M, Khurram M, et al. Hepatitis C in Pakistan: a review of available data. Hepatitis monthly. 2010; 10(3):205-14. Epub 2010/07/01. PMID: 22308140; PubMed Central PMCID: PMCPmc3269085.
99. The World Factbook. 2015. Available at: https://www.cia.gov/library/publications/the-world-factbook/.
100. Zou S, Dorsey KA, Notari EP, Foster GA, Krysztof DE, Musavi F, et al. Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion. 2010; 50(7):1495-504. doi: 10.1111/j.1537-2995.2010.02622.x PMID: 20345570.
101. Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Annals of internal medicine. 2014; 160(5):293-300. doi: 10.7326/M13-1133 PMID: 24737271.
102. Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS. Hepatitis C seroprevalence and HIV coinfection in sub-Saharan Africa: a systematic review and meta-analysis. The Lancet Infectious diseases. 2015. Epub 2015/05/10. doi: 10.1016/s1473-3099(15)00006-7 PMID: 25957078.
103. Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. The Lancet Infectious diseases. 2002; 2(5):293-302. Epub 2002/06/14. PMID: 12062995.
104. Riou J, Ait Ahmed M, Blake A, Vozlinsky S, Brichler S, Eholie S, et al. Hepatitis C virus seroprevalence in adults in Africa: a systematic review and meta-analysis. Journal of viral hepatitis. 2015. Epub 2015/10/20. doi: 10.1111/jvh.12481 PMID: 26477881.
105. Arya SC. Risk factors for acquisition of hepatitis C virus infection in Saudi Arabia. Annals of Saudi medicine. 1996; 16(2):229. Epub 1996/03/01. PMID: 17372491.
106. WHO. Hepatitis C. 2015 Availables at: http://www.who.int/mediacentre/factsheets/fs164/en/.
107. WHO. Hepatitis B. 2015 Availables at: http://www.who.int/mediacentre/factsheets/fs204/en/.
108. Abd El-Wahab E, Mikheal A, Sidkey F, Shatat HZ. Factors Associated with Hepatitis C Infection among Chronic HCV Egyptian Patients. Iranian journal of public health. 2014; 43(11):1510-8. Epub 2015/06/11. PMID: 26060718; PubMed Central PMCID: PMCPmc4449500.
109. Kiyosawa K, Tanaka E, Sodeyama T, Yoshizawa K, Yabu K, Furuta K, et al. Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group. Gastroenterology. 1994; 106(6):1596-602. Epub 1994/06/01. PMID: 8194707.
110. Alter MJ. Epidemiology of hepatitis C virus infection. World journal of gastroenterology: WJG. 2007; 13(17):2436-41. PMID: 17552026; PubMed Central PMCID: PMC4146761.
111. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. The Lancet Infectious diseases. 2005; 5(9):558-67. doi: 10.1016/S1473-3099(05)70216-4 PMID: 16122679.
112. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Annals of internal medicine. 2006; 144 (10):705-14. PMID: 16702586.
113. Mumtaz GR, Weiss HA, Thomas SL, Riome S, Setayesh H, Riedner G, et al. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis. PLoS medicine. 2014; 11(6):e1001663. doi: 10.1371/journal.pmed.1001663 PMID: 24937136; PubMed Central PMCID: PMC4061009.
114. Bradshaw D, Matthews G, Danta M. Sexually transmitted hepatitis C infection: the new epidemic in MSM? Current opinion in infectious diseases. 2013; 26(1):66-72. Epub 2012/12/18. PMID: 23242342.
115. Mumtaz GR, Weiss HA, Abu-Raddad LJ. Hepatitis C virus and HIV infections among people who inject drugs in the Middle East and North Africa: a neglected public health burden? Journal of the International AIDS Society. 2015; 18(1):20582. Epub 2015/07/30. doi: 10.7448/ias.18.1.20582 PMID: 26221872; PubMed Central PMCID: PMCPmc4518656.
116. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet (London, England). 2011; 378(9791):571-83. Epub 2011/08/02. doi: 10.1016/s0140-6736(11)61097-0 PMID: 21802134; PubMed Central PMCID: PMCPmc3285467.
117. Mumtaz G, Hilmi N, McFarland W, Kaplan RL, Akala FA, Semini I, et al. Are HIV epidemics among men who have sex with men emerging in the Middle East and North Africa?: a systematic review and data synthesis. PLoS medicine. 2010; 8(8):e1000444. Epub 2011/08/11. doi: 10.1371/journal.pmed. 1000444 PMID: 21829329; PubMed Central PMCID: PMCPmc3149074.
118. Heijnen M, Mumtaz G, Abu-Raddad LJ. Status of HIV and hepatitis C virus infections amongst prisoners in the Middle East and North Africa. (Under preparation).
119. Mohamed HI, Saad ZM, Abd-Elreheem EM, Abd-ElGhany WM, Mohamed MS, Abd Elnaeem EA, et al. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases. Journal of infection and public health. 2013; 6(3):186-95. Epub 2013/05/15. doi: 10.1016/j.jiph.2012.12.003 PMID: 23668463.
120. Larney S, Kopinski H, Beckwith CG, Zaller ND, Jarlais DD, Hagan H, et al. Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology (Baltimore, Md). 2013; 58(4):1215-24. Epub 2013/03/19. doi: 10.1002/hep.26387 PMID: 23504650; PubMed Central PMCID: PMCPmc3723697.
121. Chemaitelly H, Mahmud S, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Afghanistan (under review). 2015.
122. WHO. WHO calls for worldwide use of "smart" syringes. 2015. Available at: http://www.who.int/mediacentre/news/releases/2015/injection-safety/en/.
123. WHO. WHO guideline on the use of safety-engineered syringes for intramuscular, intradermal and subcutaneous injections in health-care settings. Available at: http://www.who.int/injection-safety/global-campaign/injection-safety-guidline.pdf. Geneva, Swizerland: World Health Organization 2015.
124. Laboratory. G. Gilead Press Release: U.S. Food and Drug Administration Approves Gilead's Sovaldi"(Sofosbuvir) for the Treatment of Chronic Hepatitis C. Available at: http://www.gilead.com/news/press-releases/2013/12/us-food-and-drug-administration-approves-gileads-sovaldi-sofosbuvirfor-the-treatment-of-chronic-hepatitis-c 2013. Available from: http://www.gilead.com/news/pressreleases/2013/12/us-food-and-drug-administration-approves-gileads-sovaldi-sofosbuvir-for-thetreatment-of-chronic-hepatitis-c.
125. Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y. Hepatitis c treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs. Hepatology (Baltimore, Md). 2015. Epub 2015/09/22. doi: 10.1002/hep.28227 PMID: 26390137.
126. Martin NK, Vickerman P, Dore GJ, Hickman M. The hepatitis C virus epidemics in key populations (including people who inject drugs, prisoners and MSM): the use of direct-acting antivirals as treatment for prevention. Current opinion in HIV and AIDS. 2015; 10(5):374-80. Epub 2015/08/08. PMID: 26248124.
127. Cuadros DF, Branscum AJ, Miller FD, Abu-Raddad LJ. Spatial epidemiology of hepatitis C virus infection in Egypt: analyses and implications. Hepatology (Baltimore, Md). 2014; 60(4):1150-9. Epub 2014/06/11. doi: 10.1002/hep.27248 PMID: 24913187; PubMed Central PMCID: PMCPmc4282472.
128. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proceedings of the National Academy of Sciences of the United States of America. 2010; 107 (33):14757-62. Epub 2010/08/11. doi: 10.1073/pnas.1008877107 PMID: 20696911; PubMed Central PMCID: PMCPmc2930444.
129. Chemaitelly H, Abu-Raddad LJ, Miller FD. An apparent lack of epidemiologic association between hepatitis C virus knowledge and the prevalence of hepatitis C infection in a national survey in Egypt. PloS one. 2013; 8(7):e69803. Epub 2013/08/08. doi: 10.1371/journal.pone.0069803 PMID: 23922806; PubMed Central PMCID: PMCPmc3726777.
130. Benova L, Awad SF, Miller FD, Abu-Raddad LJ. Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt. Hepatology. 2015; 61(3):834-42. doi: 10.1002/hep.27596 PMID: 25366418; PubMed Central PMCID: PMC4365684.
131. Guerra J, Garenne M, Mohamed MK, Fontanet A. HCV burden of infection in Egypt: results from a nationwide survey. Journal of viral hepatitis. 2012; 19(8):560-7. doi: 10.1111/j.1365-2893.2011. 01576.x PMID: 22762140.